U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT07599839) titled 'BASE: Bronchiectasis Severity and Exacerbation Risk Study' on May 15.
Brief Summary: Non-cystic fibrosis bronchiectasis (NCFB) is a chronic airway disease characterized by permanent bronchial dilatation, impaired mucus clearance, recurrent infection, airway inflammation, and repeated exacerbations. Existing bronchiectasis severity tools are clinically useful, but many depend on prior exacerbation history, hospitalization history, subjective symptom assessment, or culture-based microbiological classification.
This prospective observational cohort study aims to develop and validate the Bronchiectasis Assessment of Severity and Exacerb...